| Helen Katherine Price, | |
|
8001 S Us Highway 75, Sherman, TX 75090-5707 | |
| (903) 532-1400 | |
| Not Available |
| Full Name | Helen Katherine Price |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 8001 S Us Highway 75, Sherman, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083230668 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 978162 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Helen Katherine Price, 8001 S Us Highway 75, Sherman, TX 75090-5707 Ph: (903) 532-1400 | Helen Katherine Price, 8001 S Us Highway 75, Sherman, TX 75090-5707 Ph: (903) 532-1400 |
News Archive
Palisade Systems, the leader In Data Loss Prevention solutions for the small- and medium-sized enterprise, today announces that Cincinnati-based Secure Content Technologies has joined its VIP Reseller Program. As a reseller, Secure Content Technologies will market Palisade Systems PacketSure solution to the small and medium enterprise market seeking a full data loss prevention solution for the various markets including the healthcare, educational and financial sectors.
Military and law-enforcement personnel repeatedly exposed to low-level blasts have significant brain changes – including an increased level of brain injury and inflammation – compared with a control group, a new study has found.
A strain of the bacteria Streptococcus pneumoniae, which can cause ear infections in children, has been detected that is resistant to all FDA-approved antibiotics for treatment of ear infections and is not covered by the pneumococcal 7-valent conjugate vaccine, according to a study in the October 17 issue of JAMA.
Any scientist who studies groups of people knows that the characteristics of the "sample" - the group of people selected for the study - can profoundly impact the study's findings. To produce the most accurate findings, a study group ought to be as similar as possible to the people in the larger population you want to say something about.
Allos Therapeutics, Inc. today announced updated data from its ongoing dose finding Phase 1 study of FOLOTYN™ (pralatrexate injection) in patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). These data were showcased during an oral presentation at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, LA.
› Verified 6 days ago
Penny Nguyen, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8001 S Us Highway 75, Sherman, TX 75090 Phone: 903-532-1400 | |
Chloe Aspire Todd, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8001 S Us Highway 75, Sherman, TX 75090 Phone: 903-532-1400 | |
Tara Nichelle Batista, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8001 S Us Highway 75, Sherman, TX 75090 Phone: 832-458-4099 | |
Candace Rene Mcnutt, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8001 S Us Highway 75, Sherman, TX 75090 Phone: 903-532-1400 | |
Michelle Lynn Robinson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8001 S Us Highway 75, Sherman, TX 75090 Phone: 903-532-1400 | |
Jeanne Denise Evans, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8001 S Us Highway 75, Sherman, TX 75090 Phone: 903-532-1400 |